Key result
A vecuronium-adjusted dosing regimen of sugammadex significantly reduced the mean time to recovery of a TOF ratio of 0.9 to 5.12 minutes compared to 12.6 minutes with neostigmine.
Why the study?
Does a vecuronium-adjusted dosing regimen of sugammadex reduce neuromuscular blockade reversal time compared to neostigmine in adult patients undergoing general anesthesia?
Observational (n=20)
Open-label
No
Does a vecuronium-adjusted dosing regimen of sugammadex reduce neuromuscular blockade reversal time compared to neostigmine in adult patients undergoing general anesthesia?
Absolute Event Rate: 5.12% vs 12.6%
p-value: p=<0.05
A new vecuronium-adjusted dosing regimen for sugammadex significantly reduced neuromuscular blockade reversal time compared to neostigmine and substantially lowered drug costs.
May shorten reversal times clinically; leaves open confirmation in randomized trials.
No takes yet. Share an insight, caveat, or question.
Peček et al. (2015) conducted an observational in Vecuronium-induced neuromuscular block (n=20). Sugammadex vs. Neostigmine and atropine was evaluated on Time to recovery to a TOF ratio of 0.9 (minutes) (p=<0.05). A vecuronium-adjusted dosing regimen of sugammadex significantly reduced the mean time to recovery of a TOF ratio of 0.9 to 5.12 minutes compared to 12.6 minutes with neostigmine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: